A data-driven approach can identify distinct subgroups of HFpEF patients with different prognostic trajectories.
May refine HFpEF prognosis; leaves open whether subgroups guide therapy or require prospective validation.
Using a data-driven approach, we identified HFpEF subgroups with significantly different prognoses. Further development of this approach for characterizing HFpEF subgroups is warranted.
No takes yet. Share an insight, caveat, or question.
Kao et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: